Doxazosin
- Product NDC
- 50090-7803
- 11-digit product format
- 500907803
- Labeler code
- 50090
- Product ID
- 50090-7803_e24e0c54-4277-4688-afec-0b42f79fc6c7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Doxazosin Mesylate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA075536
- Marketing category
- ANDA
- Marketing start
- 2014-09-09
- Substance
- DOXAZOSIN MESYLATE
- Active strength
- 4 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Doxazosin
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DOXAZOSIN MESYLATE | 4 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 86P6PQK0MU |
| Rxcui | 197627 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50090-7803-0 | Doxazosin | 30 in 1 BOTTLE | TABLET | 30 | | 12 |
| 50090-7803-1 | Doxazosin | 100 in 1 BOTTLE | TABLET | 100 | | 12 |
| 50090-7803-2 | Doxazosin | 90 in 1 BOTTLE | TABLET | 90 | | 12 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 50090-7803-0 | 50090780300 | 30 TABLET in 1 BOTTLE (50090-7803-0) | 30 tablet | 2025-12-01 | No | No | Historical |
| 50090-7803-1 | 50090780301 | 100 TABLET in 1 BOTTLE (50090-7803-1) | 100 tablet | 2025-12-01 | No | No | Historical |
| 50090-7803-2 | 50090780302 | 90 TABLET in 1 BOTTLE (50090-7803-2) | 90 tablet | 2025-12-01 | No | No | Historical |